What is the share price of Sandu Pharmaceuticals Ltd (SANDUPHQ) today?

The share price of SANDUPHQ as on 1st July 2025 is ₹50.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Sandu Pharmaceuticals Ltd (SANDUPHQ) share?

The past returns of Sandu Pharmaceuticals Ltd (SANDUPHQ) share are Past 1 week: 0.50% Past 1 month: -5.30% Past 3 months: 0.30% Past 6 months: -10.94% Past 1 year: -13.33% Past 3 years: -22.43% Past 5 years: 156.52%

What are the peers or stocks similar to Sandu Pharmaceuticals Ltd (SANDUPHQ)?

The peers or stocks similar to Sandu Pharmaceuticals Ltd (SANDUPHQ) include: Sandu Pharmaceuticals Ltd Godrej Consumer Products Ltd Marico Ltd Dabur India Ltd Colgate-Palmolive (India) Ltd Procter & Gamble Hygiene and Health Care Ltd

What is the market cap of Sandu Pharmaceuticals Ltd (SANDUPHQ) share?

Market capitalization, short for market cap , is the market value of a publicly traded company's outstanding shares. The market cap of Sandu Pharmaceuticals Ltd (SANDUPHQ) is ₹48.45 Cr as of 1st July 2025.

What is the 52 week high and low of Sandu Pharmaceuticals Ltd (SANDUPHQ) share?

The 52-week high of Sandu Pharmaceuticals Ltd (SANDUPHQ) is ₹69.50 and the 52-week low is ₹43.75.

What is the PE and PB ratio of Sandu Pharmaceuticals Ltd (SANDUPHQ) stock?

The P/E (price-to-earnings) ratio of Sandu Pharmaceuticals Ltd (SANDUPHQ) is 31.26. The P/B (price-to-book) ratio is 1.19.

Which sector does Sandu Pharmaceuticals Ltd (SANDUPHQ) belong to?

Sandu Pharmaceuticals Ltd (SANDUPHQ) belongs to the Consumer Staples sector & FMCG - Personal Products sub-sector.

How to buy Sandu Pharmaceuticals Ltd (SANDUPHQ) shares?

You can directly buy Sandu Pharmaceuticals Ltd (SANDUPHQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Sandu Pharmaceuticals Ltd

SANDUPHQ Share Price

50.150.00% (+0.00)

Consumer Staples

FMCG - Personal Products

Smallcap

With a market cap of ₹48 cr, stock is ranked 3,596

Moderate Risk

Stock is 2.84x as volatile as Nifty

SANDUPHQ Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Consumer Staples

FMCG - Personal Products

Smallcap

With a market cap of ₹48 cr, stock is ranked 3,596

Moderate Risk

Stock is 2.84x as volatile as Nifty

SANDUPHQ Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
31.26	1.19	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.46	9.45	1.68%

SANDUPHQ Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

SANDUPHQ Company Profile

Sandu Pharmaceuticals is engaged in manufacturing and marketing of ayurvedic medicine

SANDUPHQ Similar Stocks (Peers)

Compare with peers Compare with peers

SANDUPHQ Similar Stocks (Peers)

Compare with peers Compare with peers

Godrej Consumer Products Ltd

GODREJCP

PE Ratio

64.54

1Y Return

16.41%

Buy Reco %

79.41

Marico Ltd

MARICO

PE Ratio

57.00

1Y Return

15.60%

Buy Reco %

77.14

Dabur India Ltd

DABUR

PE Ratio

48.41

1Y Return

21.04%

Buy Reco %

41.67

Colgate-Palmolive (India) Ltd

COLPAL

PE Ratio

45.62

1Y Return

15.79%

Buy Reco %

48.15

Procter & Gamble Hygiene and Health Care Ltd

PGHH

PE Ratio

64.04

1Y Return

20.40%

Buy Reco %

50.00

Compare with Peers

SANDUPHQ Forecast

SANDUPHQ Forecasts

SANDUPHQ

Income

Balance Sheet

Cash Flow

SANDUPHQ Income Statement

Financial Year		FY 2022		FY 2023		FY 2024	FY 2025	TTM
Total Revenue	65.58	65.68	67.70	67.36	67.36
Raw Materials	62.63	34.27	30.94	64.43	64.43
Power & Fuel Cost		0.39	0.41
Employee Cost		11.10	10.07
Selling & Administrative Expenses		13.75	15.24
Operating & Other expenses		3.35	8.32
EBITDA	2.95	2.82	2.72	2.93	2.93
Depreciation/Amortization	0.53	0.52	0.58	0.67	0.67
PBIT	2.42	2.30	2.14	2.26	2.26
Interest & Other Items	0.11	0.08	0.06	0.10	0.11
PBT	2.31	2.22	2.08	2.16	2.15
Taxes & Other Items	0.73	0.69	0.61	0.61	0.60
Net Income	1.58	1.53	1.47	1.55	1.55
EPS	1.99	1.58	1.52	1.60	1.60
DPS	—	0.00	0.80	0.00	0.80
Payout ratio	0.00	0.00	0.53	0.00	0.50

SANDUPHQ Income Statement

Quarter		dec 2022		mar 2023		jun 2023		sep 2023		dec 2023	mar 2024	jun 2024	sep 2024	dec 2024	mar 2025
Total Revenue	17.12	15.31	17.66	16.69	17.46	15.91	17.09	17.73	18.40	14.14
Operating & Other expenses	16.27	14.78	17.30	15.78	16.92	14.99	16.64	16.79	17.38	13.62
EBITDA	0.85	0.53	0.36	0.91	0.54	0.92	0.45	0.94	1.02	0.52
Depreciation/Amortization	0.13	0.13	0.12	0.13	0.14	0.19	0.16	0.17	0.19	0.15
PBIT	0.72	0.40	0.24	0.78	0.40	0.73	0.29	0.77	0.83	0.37
Interest & Other Items	0.02	0.02	0.02	0.01	0.02	0.01	0.02	0.03	0.03	0.03
PBT	0.70	0.38	0.22	0.77	0.38	0.72	0.27	0.74	0.80	0.34
Taxes & Other Items	0.21	0.10	0.10	0.21	0.17	0.12	0.11	0.24	0.24	0.01
Net Income	0.49	0.28	0.12	0.56	0.21	0.60	0.16	0.50	0.56	0.33
EPS	0.51	0.26	0.11	0.57	0.21	0.62	0.17	1.95	0.57	0.34

SANDUPHQ Cash Flow Statement

Financial Year		FY 2023	FY 2024
Cash from Operating Activities	0.22	0.76
Cash from Investing Activities	0.54	-1.31
Cash from Financing Activities	0.58	-0.72
Net Change in Cash	+1.34	-1.27
Changes in Working Capital	-2.47	-1.72
Capital Expenditures	1.07	1.43
Free Cash Flow	-0.85	-0.67

SANDUPHQ Company Updates

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

FY 2015FY 2015

Annual report

PDF

SANDUPHQ Stock Peers

SANDUPHQ Past Performance & Peer Comparison

Comparing 3 stocks from
Consumer StaplesFMCG - Personal Products

Valuation

Technical

Forecast

Compare valuation-basic on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Sandu Pharmaceuticals Ltd	31.26	1.19	—
Godrej Consumer Products Ltd	64.54	9.49	1.71%
Marico Ltd	57.00	22.27	1.46%
Dabur India Ltd	48.41	8.30	1.66%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Sandu Pharmaceuticals Ltd	Pro
Godrej Consumer Products Ltd
Marico Ltd
Dabur India Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Sandu Pharmaceuticals Ltd	39.23%	31.34	Pro
Godrej Consumer Products Ltd	26.93%	23.71
Marico Ltd	24.12%	61.75
Dabur India Ltd	21.59%	46.45

SANDUPHQ Stock Price Comparison

Compare SANDUPHQ with any stock or ETF

SANDUPHQ

SANDUPHQ Holdings

SANDUPHQ Shareholdings

SANDUPHQ Promoter Holdings Trend

SANDUPHQ Institutional Holdings Trend

SANDUPHQ Shareholding Pattern

SANDUPHQ Shareholding History

Foreign Institutions

SANDUPHQ Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing SANDUPHQ stock

Looks like this stock is not in any smallcase yet.

SANDUPHQ Events

SANDUPHQ Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

SANDUPHQ Dividend Trend

No dividend trend available

SANDUPHQ Upcoming Dividends

No upcoming dividends are available

SANDUPHQ Past Dividends

Cash Dividend

Ex DateEx DateSep 19, 2024

Final

Final | Div/Share: ₹0.80

Dividend/Share

₹0.80

Ex DateEx Date

Sep 19, 2024

Cash Dividend

Ex DateEx DateSep 18, 2023

Final

Final | Div/Share: ₹0.75

Dividend/Share

₹0.75

Ex DateEx Date

Sep 18, 2023

Cash Dividend

Ex DateEx DateSep 23, 2022

Final

Final | Div/Share: ₹0.75

Dividend/Share

₹0.75

Ex DateEx Date

Sep 23, 2022

Cash Dividend

Ex DateEx DateSep 22, 2021

Final

Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 22, 2021

SANDUPHQ Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

SANDUPHQ Upcoming Announcements

No upcoming announcements are available

SANDUPHQ Past Announcements

Insider Trading / SAST

Announced OnJun 24, 2025

Sandu Pharmaceuticals Ltd - 524703 - Clo

Sandu Pharmaceuticals Ltd - 524703 - Clo Download

Link

Download

Announced On

Jun 24, 2025

Company Update

Announced OnJun 4, 2025

Sandu Pharmaceuticals Ltd - 524703 - Ann

Sandu Pharmaceuticals Ltd - 524703 - Ann Download

Link

Download

Announced On

Jun 4, 2025

Company Update

Announced OnJun 3, 2025

Sandu Pharmaceuticals Ltd - 524703 - Ann

Sandu Pharmaceuticals Ltd - 524703 - Ann Download

Link

Download

Announced On

Jun 3, 2025

Company Update

Announced OnMay 30, 2025

Sandu Pharmaceuticals Ltd - 524703 - Int

Sandu Pharmaceuticals Ltd - 524703 - Int Download

Link

Download

Announced On

May 30, 2025

Company Update

Announced OnMay 30, 2025

Sandu Pharmaceuticals Ltd - 524703 - Ann

Sandu Pharmaceuticals Ltd - 524703 - Ann Download

Link

Download

Announced On

May 30, 2025

SANDUPHQ Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

SANDUPHQ Stock News & Opinions

Corporate

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 0.8 per equity Share (i.e. 8%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter

Net profit of Sandu Pharmaceuticals declined 44.07% to Rs 0.33 crore in the quarter ended March 2025 as against Rs 0.59 crore during the previous quarter ended March 2024. Sales declined 9.81% to Rs 14.07 crore in the quarter ended March 2025 as against Rs 15.60 crore during the previous quarter ended March 2024. For the full year,net profit rose 6.16% to Rs 1.55 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 0.13% to Rs 67.19 crore in the year ended March 2025 as against Rs 67.28 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales14.0715.60 -10 67.1967.28 0 OPM %3.203.85 -4.113.42 - PBDT0.490.91 -46 2.832.66 6 PBT0.340.72 -53 2.162.07 4 NP0.330.59 -44 1.551.46 6 Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Sandu Pharmaceuticals to table results

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Sandu Pharmaceuticals standalone net profit rises 166.67% in the December 2024 quarter

Net profit of Sandu Pharmaceuticals rose 166.67% to Rs 0.56 crore in the quarter ended December 2024 as against Rs 0.21 crore during the previous quarter ended December 2023. Sales rose 5.39% to Rs 18.37 crore in the quarter ended December 2024 as against Rs 17.43 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales18.3717.43 5 OPM %5.442.93 - PBDT0.990.52 90 PBT0.800.38 111 NP0.560.21 167 Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Sandu Pharmaceuticals to convene board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Earnings

Sandu Pharmaceuticals consolidated net profit declines 9.09% in the September 2024 quarter

Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter ended September 2023. Sales rose 6.56% to Rs 17.70 crore in the quarter ended September 2024 as against Rs 16.61 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales17.7016.61 7 OPM %5.144.94 - PBDT0.910.90 1 PBT0.740.76 -3 NP0.500.55 -9 Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter

Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter ended September 2023. Sales rose 6.56% to Rs 17.70 crore in the quarter ended September 2024 as against Rs 16.61 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales17.7016.61 7 OPM %5.144.88 - PBDT0.910.89 2 PBT0.740.76 -3 NP0.500.55 -9 Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Sandu Pharmaceuticals declare Quarterly Result

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 August 2024, inter alia, have recommended the final dividend of Rs 0.8 per equity Share (i.e. 8%) , subject to the approval of the shareholders.Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

What is the share price of Sandu Pharmaceuticals Ltd (SANDUPHQ) today?
The share price of SANDUPHQ as on 1st July 2025 is ₹50.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Sandu Pharmaceuticals Ltd (SANDUPHQ) share?
The past returns of Sandu Pharmaceuticals Ltd (SANDUPHQ) share are
- Past 1 week: 0.50%
- Past 1 month: -5.30%
- Past 3 months: 0.30%
- Past 6 months: -10.94%
- Past 1 year: -13.33%
- Past 3 years: -22.43%
- Past 5 years: 156.52%
What are the peers or stocks similar to Sandu Pharmaceuticals Ltd (SANDUPHQ)?
The peers or stocks similar to Sandu Pharmaceuticals Ltd (SANDUPHQ) include:
What is the market cap of Sandu Pharmaceuticals Ltd (SANDUPHQ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sandu Pharmaceuticals Ltd (SANDUPHQ) is ₹48.45 Cr as of 1st July 2025.
What is the 52 week high and low of Sandu Pharmaceuticals Ltd (SANDUPHQ) share?
The 52-week high of Sandu Pharmaceuticals Ltd (SANDUPHQ) is ₹69.50 and the 52-week low is ₹43.75.
What is the PE and PB ratio of Sandu Pharmaceuticals Ltd (SANDUPHQ) stock?
The P/E (price-to-earnings) ratio of Sandu Pharmaceuticals Ltd (SANDUPHQ) is 31.26. The P/B (price-to-book) ratio is 1.19.
Which sector does Sandu Pharmaceuticals Ltd (SANDUPHQ) belong to?
Sandu Pharmaceuticals Ltd (SANDUPHQ) belongs to the Consumer Staples sector & FMCG - Personal Products sub-sector.
How to buy Sandu Pharmaceuticals Ltd (SANDUPHQ) shares?
You can directly buy Sandu Pharmaceuticals Ltd (SANDUPHQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.